These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 27798488)
1. Challenges in the health economics of familial hypercholesterolemia. Norman R; Watts GF; Weintraub W; Gidding SS Curr Opin Lipidol; 2016 Dec; 27(6):563-569. PubMed ID: 27798488 [TBL] [Abstract][Full Text] [Related]
2. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Robinson JG J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States. Chen CX; Hay JW Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270 [TBL] [Abstract][Full Text] [Related]
4. An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemia. Broekhuizen K; van Wier MF; Koppes LL; Brug J; van Mechelen W; Bosmans JE; van Poppel MN BMC Res Notes; 2015 Jul; 8():317. PubMed ID: 26219281 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159 [TBL] [Abstract][Full Text] [Related]
6. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439 [TBL] [Abstract][Full Text] [Related]
9. Identification of people with heterozygous familial hypercholesterolemia. Haase A; Goldberg AC Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386 [TBL] [Abstract][Full Text] [Related]
10. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations. Shiroiwa T; Fukuda T; Ikeda S; Takura T Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183 [TBL] [Abstract][Full Text] [Related]
11. Early initiation of statin treatment in children with familial hypercholesterolaemia. Braamskamp MJ; Hutten BA; Wiegman A Curr Opin Lipidol; 2015 Jun; 26(3):236-9. PubMed ID: 25943840 [TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations. Watts GF; Juniper A; van Bockxmeer F; Ademi Z; Liew D; O'Leary P Int J Evid Based Healthc; 2012 Sep; 10(3):211-21. PubMed ID: 22925618 [TBL] [Abstract][Full Text] [Related]
14. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Goldberg AC; Robinson JG; Cromwell WC; Ross JL; Ziajka PE J Clin Lipidol; 2011 Jun; 5(3 Suppl):S46-51. PubMed ID: 21600529 [No Abstract] [Full Text] [Related]
15. Familial hypercholesterolemia in children and adolescents. McCrindle BW Curr Opin Lipidol; 2012 Dec; 23(6):525-31. PubMed ID: 22914663 [TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of economic evaluations: utility or futility? Anderson R Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354 [TBL] [Abstract][Full Text] [Related]
18. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia. Sibley C; McGann S; Stone NJ Am J Cardiol; 2004 Sep; 94(5):699-700. PubMed ID: 15342318 [TBL] [Abstract][Full Text] [Related]
19. The role of registries and genetic databases in familial hypercholesterolemia. Kindt I; Mata P; Knowles JW Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870 [TBL] [Abstract][Full Text] [Related]